As Pioneer Floating Rate Tr (PHD) Stock Price Rose, Camarda Financial Advisors Has Cut Stake by $868,758; Sector Gamma As Has Lowered Stake in Integra Lifesciences Hldgs C (IART) by $1.06 Million as Shares Rose

April 17, 2018 - By Marie Mckinney

Camarda Financial Advisors Llc decreased its stake in Pioneer Floating Rate Tr (PHD) by 14.02% based on its latest 2017Q4 regulatory filing with the SEC. Camarda Financial Advisors Llc sold 78,978 shares as the company’s stock rose 0.17% while stock markets declined. The institutional investor held 484,457 shares of the company at the end of 2017Q4, valued at $5.56 million, down from 563,435 at the end of the previous reported quarter. Camarda Financial Advisors Llc who had been investing in Pioneer Floating Rate Tr for a number of months, seems to be less bullish one the $289.68M market cap company. The stock increased 0.26% or $0.03 during the last trading session, reaching $11.71. About 46,357 shares traded. Pioneer Floating Rate Trust (NYSE:PHD) has declined 5.65% since April 17, 2017 and is downtrending. It has underperformed by 17.20% the S&P500.

Sector Gamma As decreased its stake in Integra Lifesciences Hldgs C (IART) by 4.27% based on its latest 2017Q4 regulatory filing with the SEC. Sector Gamma As sold 22,600 shares as the company’s stock rose 10.84% while stock markets declined. The institutional investor held 506,630 shares of the laboratory analytical instruments company at the end of 2017Q4, valued at $24.25M, down from 529,230 at the end of the previous reported quarter. Sector Gamma As who had been investing in Integra Lifesciences Hldgs C for a number of months, seems to be less bullish one the $4.44B market cap company. The stock increased 0.52% or $0.29 during the last trading session, reaching $56.18. About 311,128 shares traded. Integra LifeSciences Holdings Corporation (NASDAQ:IART) has risen 29.35% since April 17, 2017 and is uptrending. It has outperformed by 17.80% the S&P500.

Analysts await Integra LifeSciences Holdings Corporation (NASDAQ:IART) to report earnings on April, 25 before the open. They expect $0.49 earnings per share, up 25.64% or $0.10 from last year’s $0.39 per share. IART’s profit will be $38.69M for 28.66 P/E if the $0.49 EPS becomes a reality. After $0.64 actual earnings per share reported by Integra LifeSciences Holdings Corporation for the previous quarter, Wall Street now forecasts -23.44% negative EPS growth.

Sector Gamma As, which manages about $594.94M US Long portfolio, upped its stake in Gilead Sciences Inc (NASDAQ:GILD) by 22,200 shares to 357,890 shares, valued at $25.64M in 2017Q4, according to the filing. It also increased its holding in Boston Scientific Corp (NYSE:BSX) by 232,000 shares in the quarter, for a total of 1.70 million shares, and has risen its stake in Astrazeneca Plc (NYSE:AZN).

Among 16 analysts covering Integra Lifesciences Holdings Corp. (NASDAQ:IART), 8 have Buy rating, 0 Sell and 8 Hold. Therefore 50% are positive. Integra Lifesciences Holdings Corp. had 39 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Thursday, March 29 by Oppenheimer. The stock has “Neutral” rating by Bank of America on Tuesday, January 2. The stock of Integra LifeSciences Holdings Corporation (NASDAQ:IART) earned “Outperform” rating by Raymond James on Wednesday, July 29. The rating was maintained by Barclays Capital on Friday, July 29 with “Equal Weight”. The rating was maintained by Lake Street on Thursday, April 28 with “Hold”. RBC Capital Markets maintained the shares of IART in report on Friday, January 13 with “Sector Perform” rating. On Friday, October 28 the stock rating was upgraded by Lake Street to “Buy”. Citigroup initiated Integra LifeSciences Holdings Corporation (NASDAQ:IART) rating on Thursday, November 12. Citigroup has “Buy” rating and $75 target. JP Morgan downgraded the stock to “Neutral” rating in Friday, October 27 report. JMP Securities upgraded the stock to “Mkt Outperform” rating in Friday, January 6 report.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: